Furthermore, incubation with APR-246 reduced cell viability after ASNase treatment in several of the tested ALL cell lines, for example, in MOLT-16 and Jurkat A3 with low p53 levels and CCRF-CEM cells with high p53 levels (Figs. 4B and S4A). Here, TP53 is linked to acute lymphoblastic leukemia.